Categories

Tag: The Industry

INDUSTRY/TECHNOLOGY: How GE Medical helped boost offshoring to India, with UPDATE

This is a great article from the WSJ (but reprinted in another paper so you can see it) about how outsourcing to India was  in part driven by the medical products group of GE. I am not in general an opponent of outsourcing per se. There is obviously pain and dislocation for workers in richer nations as their jobs get sent to poorer one, and in the US  both government and corporations (as if there’s any difference any more) do a shoddy job in retraining and softening the blow to workers here. But moving up the value curve is part of Schumpeter’s creative destruction.  And of course India needs the money more than we do. How we distribute the money (and the work remaining here) is a political decision.

Meanwhile I recall that my colleague David Hansen wrote an article in the 1995 Institute for the Future 10 Year Forecast suggesting that significant chunks of the then growing high-tech economy in the US would find that their jobs could be moved off-shore due to the very technology that they were creating.

Recently I’ve been investigating working with some research companies in India.  Many major research companies are already outsourcing large parts of their research activities to India (after all Google works there too!).  And although the rates are cheaper than in the US, they’re not that much cheaper.  So methinks this trend overall will level off.
On a related topic, at the excellent HIS Talk blog, read what one CEO of a transcription company has to say about the future of medical transcription being done overseas.  He thinks that trend is ending too.The transcription part is only a piece of long and fascinating interview. Kudos to the HIS Talk blog for getting this type of informed opinion out there.

UPDATE: David Hansen has sent me copies of the two articles he wrote for the 1995 IFTF Ten Year Forecast.  One is about India called India Strides Into The Information Age
Dragging One Foot In Its Past
and the other is a wildcard called InfoSerfing that suggests that US white collar workers might find their incomes dropping dramatically due to the exporting of their jobs to similarly skilled people in other countries (just as happened to factory workers). Both pretty prescient articles given that we’re ten years on now.

INDUSTRY: The Birmingham kid is innocent!

As the trial begins of Healthsouth CEO Richard Scrushy for the largest outright health care fraud ever, it’s good to know that in America you can start a huge company from nothing, be totally responsible for all its success, pay yourself vast amounts of money–enough not only to buy all the cars, houses and planes you need but also to sponsor Christian rock boy bands and hire in actors from The Wonder Years as PR Monkeys–and go through seemingly dozens of CFOs. And all the while you never need to have any idea at all about the financial state of your own company.

POLICY/INDUSTRY: Costs — The rate of increase decreases, but not enough to spoil everyone’s party, with UPDATE

There’s a confusing little piece in the WSJ about how health spending continues to rise at (a) worrying pace. It’s based on a HSC report and an EBRI report about the first half of this year, which suggest that last year’s trends are continuing. Incidentally neither of those reports seem to appear on those organizations’ websites for us mere mortals. The report is now up on HSC’s site,(although perhaps the SEC should be investigating how the WSJ got it early?) However, last year’s trends were a slowing to a mere 7.5% increase, which is only a little over double GDP growth. Anyway this is pretty much in line with CMS’ projection of a 7.8% rise in costs for 2003. A more nuanced observer might notice that it’s during recessions when we have double digit health care cost growth (e.g. 1990-2 and 2001-2) that the healthcare as a share of GDP number really takes off. The rest of the time it just continues a slow snake-like growth upwards. But this isn’t stopping the WSJ from panicking:

The finding suggests that health costs may continue to increase at unmanageable levels for employers and consumers. That outlook is distressing, because until recently the rise in health-care costs had appeared to be decelerating. The flattening of health-cost increases suggests health-insurance premiums will continue to rise at a similar pace.

But of course if you look in the other part of the WSJ you might notice that yesterday was a pretty good day for one part of the health sector–the insurers. Part of that was more irrational exuberance about the finalization of the Wellpoint/Anthem deal. But part of that increase was a big bump in the numbers and forecasts for Humana and Cigna and even bigger jumps in their stock prices. (Incidentally, can anyone else remember a merger going from final government approval one day to immediate ticker symbol transfer and final merger the next? I can’t but that’s what happened and Wednesday WLP stopped trading and handed its symbol over to ATH, which–now called WLP–went up another 7%!).

So if you were concerned about where all those extra premiums are going, don’t be. The health plans are looking after them very well indeed!

UPDATE: And if you needed proof of the frugality of health plans, Bill McGuire, CEO of United, is cashing in $114m in stock options, barely more than the $94m in total comp he had to scrape by on last year. Do you ever wonder if the tough captains of American industry ever stop to think that the more they are asked to pay for health care, the richer the health plans seem to get? Is that how generously they treat the rest of their suppliers?

INDUSTRY: Is nothing sacred? Cardinal admits sinning

OK, not really, but serious bad news at what has been one on the health care industry strongest performers and best run companies. Cardinal Health anounced that it would miss profit forecasts, and was being investigated by the SEC. The stock is off 25%. The Street.com has (for them) a balanced article including this juicy quote from one analyst: ‘Multiple investigations, lowered guidance and a hazy outlook on growth have shaken our thesis that CAH is a ‘buy and hold forever’ stock,’ Wieland concluded.". Of course regular THCB readers know what’s coming next. I bought a small amount of Cardinal stock on a slight dip as part of my "sensible" portfolio last month! Oh well, back to crazy biotech companies with no revenue–they’re clearly safer!

INDUSTRY: JSK on transparency in health care

Just a quick one for today. Go read Jane Sarasohn Kahn’s article on "transparency" in her iHealthbeat column. Then consider if the recent Supreme Court decision not allowing health plans to be sued by their members increases or decreases their incentives to be "transparent".

INDUSTRY: Consolidation in the health care sector

Today looks like a big day for more consolidation. Big drug chain CVS is getting bigger by buying part of the Eckerd chain owned by JC Penny. The other part is being bought by Canadian chain Jean Coutu Group.

In the health plan sector Oxford Health Plans is up 10% up on strong rumors that it will be bought by Wellchoice, the for-profit company that used to be Empire Health Plans, the New York City Blues plan. This is an interesting one, as it may be the first time that a Blues plan has gone outside the Blues system for an aquistion. Almost every other Blues plan has grown by aquiring other Blues, with the Anthem/Wellpoint merger being the latest example.

CONSUMERS/INDUSTRY: Reggie’s back and the intellectual slop goes on

Regina Herzlinger is back and has now moved from Market Driven HealthCare (which in my view produced one of the best letters ever to Health Affairs from Jamie Robinson following her disputing of his review) to a new tome called Consumer-Driven Health Care: Implications for Providers, Players, and Policy-Makers. The new book is basically 7 chapters from Herzlinger and a ton of short pieces (600 pages worth) describing a grab-bag of "innovations" in health care.

Trying to define, understand or explain Herzlinger’s points is maddening, as poor old Jamie Robinson found out–he ges well slagged off in this book in multiple places, mostly for making the mistake of interviewing the CEO of Aetna as he was walking out the door–Reggie though remembers that nasty review. She wraps in so many anecdotes, so many stories, and includes so many variants of health services and insurance packages that what she actually thinks will work is baffling. The market will sort it out. But of course, not the market as we now know it (that for instance Don Johnson supports). She agrees that we need some form of change to the current set of market incentives. But she never actually explains what it is that’s going to get us from our current dud system (on which we are agreed) to the consumer-centered nirvana. What type of changes to the tax laws, what about Medicare, how can you mandate risk adjustment? All big deals and all ignored.

This postulating a bunch of stories, flitting from one to another unrelated issue page by page, and not really getting to a solid intellectual explanation is exactly the problem Market-Driven Healthcare had. And of course there was neither a number nor a date in her book–she really understands how to be a forecaster! Well I suppose she nearly titled the book right. As the pharma industry showed us by spending $3bn a year advertising Rx drugs, it should have been called Marketing Driven Healthcare.

I think what she concludes in the latest tome is that Enthoven-style managed competition is a failure, even though it was never tried, but that it can be replaced with giving individuals the right to buy different assortments of flavor of health plan, using their own HSAs, and using highly complex risk adjustment to make sure no one games the system, and that insurers only seek out healthy people to insure. Providers will immediately respond by creating clear bundled pricing for disease states, or episodes of care, or something, these will be offered to insurers, or is it consumers, or is it both, and everyone will wonder happily into the sunset.

And how are we going toa) get everyone into these systems, particularly those who are in Medicare, where the real money is spent?b) cross-subsidize within a group when 80% of the money is spent on 20% of the people?c) pay for the care of the uninsured, rather than allowing them to be gamed out of insurance via underwriting?d) get the providers to actually create these bundled pricing schemes, when her own book shows that the only providers who ever had an incentive to figure out their costs for different care processes (the fully capitated California medical groups in the 1990s) couldn’t figure out their real cost structures?

Oh, all just details, details that Reggie doesn’t seem to think require explanation. According to her introduction she won the best teacher at Harvard award. Either she manages a much higher level of intellectual clarity in the rarified atmosphere of Cambridge than she gets on paper, or those Harvard MBAs are rather less demanding than their equivalents at Stanford.

Reading these two books is just so frustrating. Most of her criticisms of the current system are identical to the pro-managed competition crowd’s–about excessive provider power, perverse incentives, limited information about quality, low use of information systems, etc, etc. But she doesn’t ever give a clear view about what she thinks ought to be done to get from here to there. Or bother defending her ideas properly from the "naysayers" that she attacks. Somewhere in here there are some interesting ideas trying to get out. I just don’t think Reggie is going to be the one to explain them. That of course won’t stop her going on the lecture circuit and making a packet.

My final thoughts? Well as we’re dealing with Reggie, true to her style they’re just random anecdotes. First, when I saw her talk in 1998 she gave the presentation, made all these bold assertions and left without taking a single question. That was symbolic to me. Secondly, she spends a great deal of energy slagging off the single-payer and European models. But her favorite example of a really successful health care focus factory is the Shouldice institute for hernia repair in Toronto. You recall Toronto, it’s in Canada, and this care is all paid for by the single payer system in which the focused factory has thrived, without any help from self-actualizing consumers. But sadly even there the story isn’t that great. A 2001 clinical trial found that the Shouldice technique wasn’t as good as one from Lichenstein. So it’s another example of a North American factory being outdone by a foreign one.

The sad thing is that there is something to the concept of consumers making intelligent choices with their own money. Thrid party payment with cost-unconcious payers and guild-model providers is what got us into this mess. So something needs to replace it. The consumer movement needs as honest an intellectual theorist as Alain Enthoven is to the managed competition model or Steffi Wollhandler is to single payer. Regina Herzlinger is not it. But she sure sells a lot more books than they do.

INDUSTRY: PPM evolution–US Oncology to be bought

Buy-out fund Welsh, Carson has bought the biggest for-profit physician group US Oncology. This suggests to me that the market is unlikely to be rewarding oncologists while the whole issue around reduced fees for oncology drugs gets sorted out. THCB oncology correspondent Matt Quinn agrees:

    US Oncology treats about 15% of newly diagnosed cancer patients. USON has persued a strategy of revenue growth by dominating cancer care in medium markets and by negotiating low drug prices (in relation to both other oncologists and AWP) with pharma. They also are large enough to provide critical mass for pharma drug trials… With the pharma side of the equation drying up, it appears that they think the market will react unfavorably. And perhaps they want to hide the "sausage-making" that must go on as they transition business models. I’d be interested to know the docs are reacting to this and whether and how quickly they can "cash out".

BTW if you want to know more from the guts of oncology pricing, here’s this gem from the Pete Stark archives in 2001. It was this kind of drug "pricing" strategy that eventually got CMS’ attention in the past year.

INDUSTRY/POLICY: Humphrey Taylor on the big debates in healthcare’s future

Take time this weekend to read and savor this lecture from Harris Poll Chairman, Humphrey Taylor. A witty and excellent presentation on where the system is, where it’s going and what we’re likely to be talking about in the coming years. It’s called The Big Health Care Debates That Lie Ahead. By the way, just in case you think Humphrey has pre-conceived biases having worked for Tory PM Ted Heath in the UK back in the early 1970s, he’s lived in New York for over 25 years and he told me once that the reason he has never applied for US citizenship is that as a pollster he wants to be able to remain neutral on the issues!

INDUSTRY: Scrushy goes on TV with Roy Moore to proclaim innocence

It’s so hard to resist, and I’ve been good for so long, but I had to re-open the Healthsouth file. The story so far. 15 execs admit years and years of fraud. CEO Richard Scrushy claims he knew nothing about any of it, despite the fact that plenty of his staff say he led the whole thing. Now Scrushy has his own TV chat show and his first guest was whacko Alabama chief justice Roy Moore–the one who put the Ten Commandments monument in his courthouse. Anyway, they are both agree that the media has cooked this whole thing up and Scrushy, like Ken Lay, was merely an innocent bystander while his underlings plundered and cheated the company. And if you don’t believe him, because, well, because you’re just not a trusting person, he’s got his own website to prove it!

It reminds me a little of the Chaing-Kai Shek War Memorial in Taiwan, which has a long exhibition showing how the Nationalists really won the 1949 Civil War with their strategic retreat from Beijing to Taiwan! Of course usually losers don’t get to write the history books, so it’s nice to see Scrushy joining in a rare tradition. Methinks that if Martha goes down, he’s bound to follow–but of course I won’t be on a jury in Alabama!

assetto corsa mods